View Older Stories View More Recent Stories

Aug 6, 2025 06:07AM BridgeBio Pharma (BBIO) PT Raised to $61 at Oppenheimer
Aug 5, 2025 05:47PM BridgeBio Pharma Inc. (BBIO) Misses Q2 EPS by 20c
Jul 29, 2025 04:24PM Raymond James Assumes BridgeBio Pharma (BBIO) at Outperform
Jul 29, 2025 08:25AM Cantor Fitzgerald Reiterates Overweight Rating on BridgeBio Pharma (BBIO)
Jul 23, 2025 07:31AM BridgeBio study finds ADH1 genetic condition underdiagnosed by 80%
Jul 21, 2025 07:29AM Truist Securities Starts BridgeBio Pharma (BBIO) at Buy
Jul 18, 2025 06:54AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Jul 14, 2025 05:46AM Citi Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Jul 14, 2025 12:54AM Jefferies Starts BridgeBio Pharma (BBIO) at Buy
Jul 11, 2025 07:45AM Helix Acquisition and BridgeBio Oncology receive SEC approval for merger
Jul 9, 2025 06:04AM Oppenheimer Upgrades BridgeBio Pharma (BBIO) to Outperform
Jul 3, 2025 06:43AM Cantor Fitzgerald Reiterates Overweight Rating on BridgeBio Pharma (BBIO)
Jun 30, 2025 02:27PM Raymond James Reiterates Outperform Rating on BridgeBio Pharma (BBIO)
Jun 30, 2025 10:57AM Citi Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Jun 30, 2025 07:30AM BridgeBio Pharma (BBIO) Raises $300 Million Through Partial Capped Monetization of BEYONTTRA European Royalty
Jun 17, 2025 05:53AM Wolfe Research Starts BridgeBio Pharma (BBIO) at Outperform
Jun 9, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Jun 6, 2025 07:27AM Piper Sandler Highlights an 'Under-The-Radar 2H25 Catalyst' at BridgeBio Pharma (BBIO)
Jun 4, 2025 09:05AM BridgeBio Pharma (BBIO) PT Raised to $42 at BMO Capital
May 25, 2025 03:00PM Biotech stocks Q1 earnings review
May 19, 2025 12:37PM BridgeBio Pharma Inc. (BBIO): Early and Sustained Increase in Serum TTR Levels by Acoramidis Independently Predicted Improved Survival in the ATTRibute-CM Study
May 13, 2025 07:31AM BridgeBio Pharma Inc. (BBIO): First Participant Dosed with Acoramidis in ACT-EARLY, the First Ever ATTR Primary Prevention Study
Apr 30, 2025 03:25PM BridgeBio Pharma Inc. (BBIO) call put ratio 1.2 calls to 1 put with a focus on May calls and puts as share price up 4.5%
Apr 30, 2025 07:20AM BridgeBio Pharma (BBIO) PT Raised to $55 at Scotiabank
Apr 30, 2025 01:42AM BridgeBio Pharma Inc. (BBIO) Tops Q1 EPS by 3c
Apr 11, 2025 09:44AM Piper Sandler: 'What Biotech Names to Own in Market Volatility'
Apr 10, 2025 07:31AM Piper Sandler on BridgeBio Pharma (BBIO): 'Attruby Launch In Early Innings Looks Strong'
Apr 2, 2025 07:04AM Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald
Apr 1, 2025 06:41AM Raymond James Reiterates Outperform Rating on BridgeBio Pharma (BBIO)
Mar 31, 2025 10:00AM BridgeBio Pharma (BBIO) Reports Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM
Mar 31, 2025 04:15AM Redburn-Atlantic Starts BridgeBio Pharma (BBIO) at Buy
Mar 27, 2025 07:00AM BridgeBio Pharma (BBIO) Announces Beyonttra Approved in Japan to Treat ATTR-CM
Mar 17, 2025 04:01PM BridgeBio Pharma Inc. (BBIO) appoints Thomas Trimarchi as CFO
Mar 17, 2025 07:06AM Cantor Fitzgerald says 15% of biotech companies down 40% or more
Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma
Mar 10, 2025 08:02AM Deep Track Capital Sends Letter to Dynavax Technologies’ (DVAX) Board
Mar 6, 2025 09:05AM Cantor Fitzgerald Reiterates Overweight Rating on BridgeBio Pharma (BBIO)
Feb 28, 2025 07:50AM BridgeBio Oncology Therapeutics to go Public via Merger with Helix Acquisition Cp II (HLXB)
Feb 24, 2025 04:11PM BridgeBio Pharma (BBIO) Initiates Long Term Debt Management Strategy and Announces Proposed Offering of Convertible Senior Notes to Refinance Senior Secured Debt
Feb 21, 2025 07:14AM BridgeBio Pharma (BBIO) PT Raised to $52 at Scotiabank
Feb 20, 2025 07:40AM BridgeBio Pharma Inc. (BBIO) Misses Q4 EPS by 27c
Feb 19, 2025 10:00AM Piper Sandler on BridgeBio Pharma (BBIO): 'Survey Suggests Strong Launch Dynamics For Attruby'
Feb 15, 2025 10:00PM Biotech Q4 earnings preview: Goldman Sachs
Feb 12, 2025 07:11AM BridgeBio Pharma (BBIO) PT Raised to $49 at Scotiabank
Feb 11, 2025 09:22AM BridgeBio Pharma Inc. (BBIO) Announces BEYONTTRA Approved by the European Commission to Treat ATTR-CM
Jan 13, 2025 11:00AM BridgeBio Pharma Inc. (BBIO) Announces Commercial Progress, Program Updates, and 2025 Milestones
Jan 2, 2025 12:51PM Biopharma 2025 Preview: 'Piper Sandler Sees Lots of Upside Opportunity'
Dec 18, 2024 09:08AM Piper Sandler Reiterates Overweight Rating on BridgeBio Pharma (BBIO) Following Key Investor Debate
Dec 16, 2024 06:52AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Dec 13, 2024 07:19AM BridgeBio Pharma's (BBIO) Acoramidis Receives Positive CHMP Opinion
View More Recent Stories View Older Stories